Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

What Evidence Supports Cannabis in Sleep-Apnoea Treatment? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Interest in cannabinoids as a potential therapy for obstructive sleep apnoea (OSA)  has grown, prompting an evaluation of cannabis evidence for sleep apnoea. Researchers aim to determine whether cannabinoids can reduce apnoea events, improve sleep quality, and enhance daytime functioning. 

Am I eligible for medical cannabis for pain relief?

Current Research Insights 

Existing cannabis evidence for sleep apnoea stems from clinical trials, observational studies, and preclinical research investigating cannabinoid effects on respiratory control and sleep regulation. 

Clinical Studies on Apnoea 

Clinical studies on cannabis for apnoea report that THC-based interventions, like dronabinol, may decrease apnoea-hypopnea index (AHI) in some patients. Benefits appear modest and vary by dosage and individual response. 

Mechanistic Research 

Research on cannabis for OSA suggests cannabinoids influence neurotransmitter pathways controlling respiratory rhythm, potentially stabilising breathing during sleep. 

Safety and Tolerability 

Studies also highlight side effects such as daytime sleepiness, dizziness, or cardiovascular changes, emphasizing the importance of monitoring cannabis evidence for sleep apnoea in therapeutic contexts. 

Limitations of Existing Evidence 

Most studies are small-scale with short treatment durations, limiting the ability to generalize findings broadly. 

While cannabis evidence for sleep apnoea is promising, larger and longer-term studies are needed. Current research on cannabis for OSA and clinical studies on cannabis for apnoea support cautious exploration, highlighting cannabinoids as a potential adjunct to standard therapies. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories